| Income Statement |
| Total Revenue | 420.00K |
|
| Revenues (USD) | 420.00K |
| Cost of Revenue | 261.00K |
| Gross Profit | 159.00K |
| Operating Expenses | 4.69M |
| Research and Development Expense | 2.24M |
| Selling, General and Administrative Expense | 2.45M |
| Operating Income | -4.53M |
| Net Income | -4.32M |
| Net Income Common Stock | -4.32M |
| Net Income Common Stock (USD) | -4.32M |
| Consolidated Income | -4.32M |
| Earnings per Basic Share | -0.26 |
| Earnings per Basic Share (USD) | -0.26 |
| Earnings per Diluted Share | -0.26 |
| Earning Before Interest & Taxes (EBIT) | -4.32M |
| Earning Before Interest & Taxes (USD) | -4.32M |
| Weighted Average Shares | 16.79M |
| Weighted Average Shares Diluted | 16.79M |
| Balance Sheet |
| Cash and Equivalents | 17.22M |
| Cash and Equivalents (USD) | 17.22M |
| Investments | 333.00K |
| Investments Current | 333.00K |
| Trade and Non-Trade Receivables | 1.36M |
| Current Assets | 19.91M |
| Property, Plant & Equipment Net | 1.06M |
| Total Assets | 21.38M |
| Debt Current | 588.00K |
| Total Debt | 834.00K |
| Current Liabilities | 3.42M |
| Debt Non-Current | 246.00K |
| Total Liabilities | 3.99M |
| Accumulated Retained Earnings (Deficit) | -72.51M |
| Shareholders Equity | 17.39M |
| Shareholders Equity (USD) | 17.39M |
| Assets Non-Current | 1.47M |
| Total Debt (USD) | 834.00K |
| Deferred Revenue | 342.00K |
| Inventory | 244.00K |
| Liabilities Non-Current | 564.00K |
| Trade and Non-Trade Payables | 448.00K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 29.00K |
| Net Cash Flow from Financing | 101.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -4.69M |
| Capital Expenditure | -7.00K |
| Issuance (Purchase) of Equity Shares | 101.00K |
| Net Cash Flow from Investing | -337.00K |
| Net Cash Flow - Investment Acquisitions and Disposals | -330.00K |
| Net Cash Flow from Operations | -4.46M |
| Effect of Exchange Rate Changes on Cash | 152.00K |
| Share Based Compensation | 452.00K |